Advanced BioPhotonics Inc. Closes on Second Milestone of $4.0 Financing.BOHEMIA, N.Y. -- Advanced BioPhotonics Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ABPH ABPH American Board of Psychological Hypnosis (Beverly, MA) ABPH Associated British Ports Holdings PLC (UK) ABPH Able Seaman Photographer )(Frankfurt/FSE: YP2) reported today that it has filed a registration statement on Form SB-2 with the Securities and Exchange Commission completing the second milestone of its previously announced financing. The Company received $1 million in gross proceeds that was payable upon completion of that milestone. An additional $2 million in gross proceeds will be paid at the time the registration statement becomes effective. For more details refer to the Company's Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. filed today with the SEC at http://sec.gov. "I am glad that ABPH met this milestone in an efficient and timely manner," said Denis Denis, king of Portugal: see Diniz. O'Connor, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Advanced BioPhotonics. "The proceeds will be used to continue the clinical validation necessary to fuel market adoption and revenue opportunities for our BioScanIR(R) product, which we hope will occur in the near future." About Advanced BioPhotonics Advanced BioPhotonics Inc., headquartered in Bohemia, New York Bohemia is a hamlet (and census-designated place) in Suffolk County, New York, United States. The population was 9,871 at the 2000 census. Bohemia is in the Town of Islip. , is a leading developer of functional medical imaging applications using advanced infrared technology for the observation and measurement of changes of photonic activity within tissue. Advanced BioPhotonics provides imaging technology for clinicians and researchers for, disease detection and disease management and drug discovery applications. Advanced BioPhotonics mission is to improve the quality and cost-effectiveness of healthcare services and research through identifying, acquiring and adapting high-resolution infrared technology for biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. applications. For more information about the Company and its technology, please visit http://www.advancedbp.com/. This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion